Suchergebnisse - Max Thomson

Unlocking the potential of dimethyl fumarate: enhancing oncolytic HSV-1 efficacy for wider cancer applications von Akram Alwithenani, Akram Alwithenani, Akram Alwithenani, Zaid Taha, Zaid Taha, Max Thomson, Andrew Chen, Boaz Wong, Boaz Wong, Rozanne Arulanandam, Jean-Simon Diallo, Jean-Simon Diallo

Volltext

Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus von Zaid Taha, Zaid Taha, Mathieu J.F. Crupi, Mathieu J.F. Crupi, Nouf Alluqmani, Nouf Alluqmani, Faiha Fareez, Kristy Ng, Judy Sobh, Emily Lee, Andrew Chen, Max Thomson, Marcus M. Spinelli, Carolina S. Ilkow, Carolina S. Ilkow, John C. Bell, John C. Bell, Rozanne Arulanandam, Jean-Simon Diallo, Jean-Simon Diallo

Volltext

Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy von Zaid Taha, Mathieu Joseph François Crupi, Nouf Alluqmani, Duncan MacKenzie, Sydney Vallati, Jack Timothy Whelan, Faiha Fareez, Akram Alwithenani, Julia Petryk, Andrew Chen, Marcus Mathew Spinelli, Kristy Ng, Judy Sobh, Christiano Tanese de Souza, Priya Rose Bharadwa, Timothy Kit Hin Lee, Dylan Anthony Thomas, Ben Zhen Huang, Omar Kassas, Joanna Poutou, Victoria Heather Gilchrist, Stephen Boulton, Max Thomson, Ricardo Marius, Mohsen Hooshyar, Scott McComb, Rozanne Arulanandam, Carolina Solange Ilkow, John Cameron Bell, Jean-Simon Diallo

Volltext